Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Read More

Overview

Feature Articles

Latest Vaccine News and Research

A backbone free energy study of SARS-CoV-2 variants of concern

A backbone free energy study of SARS-CoV-2 variants of concern

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

One in seven people in England show SARS-CoV-2 antibodies, finds study

One in seven people in England show SARS-CoV-2 antibodies, finds study

Black churches fill a unique role in combating vaccine fears

Black churches fill a unique role in combating vaccine fears

Connecticut is doling out vaccines based strictly on age. It’s simpler, but is it fair?

Connecticut is doling out vaccines based strictly on age. It’s simpler, but is it fair?

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

FDA issues EUA for third COVID-19 vaccine

FDA issues EUA for third COVID-19 vaccine

Pfizer-BioNTech SARS-CoV-2 vaccine effective for wide range of Covid-19–related outcomes

Pfizer-BioNTech SARS-CoV-2 vaccine effective for wide range of Covid-19–related outcomes

COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location

COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location

New SARS-CoV-2 B.1.526 variant emerges in New York

New SARS-CoV-2 B.1.526 variant emerges in New York

Giving COVID-19 vaccine priority to older people will save more lives, shows study

Giving COVID-19 vaccine priority to older people will save more lives, shows study

FDA to finalize the issuance of emergency use authorization for vaccine distribution

FDA to finalize the issuance of emergency use authorization for vaccine distribution

FDA undertakes new action in its ongoing response effort to COVID-19 pandemic

FDA undertakes new action in its ongoing response effort to COVID-19 pandemic

KHN’s ‘What the health?’: Staffing up at HHS

KHN’s ‘What the health?’: Staffing up at HHS

Neanderthal-derived protein may protect against COVID-19 susceptibility and severity

Neanderthal-derived protein may protect against COVID-19 susceptibility and severity

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America